Rab6c is a new target of miR‑218 that can promote the progression of bladder cancer-Reference-Cited by-同舟云学术

Rab6c is a new target of miR‑218 that can promote the progression of bladder cancer

Published:2021-09-10 Issue:5 Volume:24 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

He Long¹,Pan Xiang¹,Wang Xialu²,Cao Yuhua³,Chen Peng⁴,Du Cheng⁵,Huang Daifa³

Affiliation:

1. Department of Urology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu 225003, P.R. China

2. Key Laboratory of Pattern Recognition in Liaoning, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P.R. China

3. Department of The Second Cadre Ward, General Hospital of Northern Theater Command, National Center for Clinical Research of Geriatric Diseases, Shenyang, Liaoning 157099, P.R. China

4. Department of Urology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110013, P.R. China

5. Department of Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110013, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A centrosome-related gene signature for predicting the overall survival of uveal melanoma;Translational Cancer Research;2024-02

2. The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics;Frontiers in Pharmacology;2022-12-05

3. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases;Journal of Personalized Medicine;2022-05-10